Cost-Effectiveness of Pembrolizumab for Treating Previously Untreated Metastatic Melanoma Patients in France
Nov 1, 2016, 00:00
10.1016/j.jval.2016.09.2195
https://www.valueinhealthjournal.com/article/S1098-3015(16)33561-6/fulltext
Title :
Cost-Effectiveness of Pembrolizumab for Treating Previously Untreated Metastatic Melanoma Patients in France
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(16)33561-6&doi=10.1016/j.jval.2016.09.2195
First page :
A730
Section Title :
Disease-Specific Studies
Open access? :
No
Section Order :
2086